Robeco Institutional Asset Management B.V. cut its stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) by 5.5% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 111,330 shares of the company’s stock after selling 6,538 shares during the quarter. Robeco Institutional Asset Management B.V. owned 0.20% of Nu Skin Enterprises worth $9,175,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Seven Eight Capital LP acquired a new stake in shares of Nu Skin Enterprises during the third quarter worth $1,698,000. Oakbrook Investments LLC acquired a new stake in shares of Nu Skin Enterprises during the third quarter worth $297,000. MERIAN GLOBAL INVESTORS UK Ltd lifted its holdings in shares of Nu Skin Enterprises by 4.2% during the third quarter. MERIAN GLOBAL INVESTORS UK Ltd now owns 746,830 shares of the company’s stock worth $61,553,000 after purchasing an additional 29,880 shares during the period. First Hawaiian Bank acquired a new stake in shares of Nu Skin Enterprises during the third quarter worth $165,000. Finally, State of Alaska Department of Revenue lifted its holdings in shares of Nu Skin Enterprises by 120.6% during the third quarter. State of Alaska Department of Revenue now owns 13,080 shares of the company’s stock worth $1,076,000 after purchasing an additional 7,150 shares during the period. 76.13% of the stock is owned by hedge funds and other institutional investors.
In other Nu Skin Enterprises news, General Counsel D Matthew Dorny sold 2,500 shares of the firm’s stock in a transaction on Monday, October 1st. The stock was sold at an average price of $82.18, for a total value of $205,450.00. Following the completion of the sale, the general counsel now owns 33,871 shares of the company’s stock, valued at $2,783,518.78. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Edwina D. Woodbury sold 5,000 shares of the firm’s stock in a transaction on Monday, August 6th. The shares were sold at an average price of $85.02, for a total value of $425,100.00. Following the completion of the sale, the director now directly owns 11,860 shares of the company’s stock, valued at approximately $1,008,337.20. The disclosure for this sale can be found here. In the last three months, insiders sold 32,850 shares of company stock valued at $2,723,563. 5.20% of the stock is owned by corporate insiders.
Nu Skin Enterprises stock opened at $71.49 on Friday. Nu Skin Enterprises, Inc. has a one year low of $59.79 and a one year high of $88.68. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.82 and a quick ratio of 1.19. The firm has a market capitalization of $3.91 billion, a price-to-earnings ratio of 19.08, a price-to-earnings-growth ratio of 1.72 and a beta of 1.04.
Nu Skin Enterprises (NYSE:NUS) last released its earnings results on Thursday, August 2nd. The company reported $1.08 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.18. Nu Skin Enterprises had a return on equity of 25.67% and a net margin of 5.74%. The company had revenue of $704.19 million during the quarter, compared to the consensus estimate of $642.16 million. During the same quarter last year, the company earned $0.77 earnings per share. Nu Skin Enterprises’s quarterly revenue was up 28.0% compared to the same quarter last year. On average, analysts predict that Nu Skin Enterprises, Inc. will post 3.59 earnings per share for the current year.
Several equities research analysts recently weighed in on NUS shares. Jefferies Financial Group reaffirmed a “buy” rating and set a $98.00 price target on shares of Nu Skin Enterprises in a report on Tuesday, September 4th. Zacks Investment Research raised Nu Skin Enterprises from a “sell” rating to a “hold” rating in a report on Monday, October 15th. DA Davidson started coverage on Nu Skin Enterprises in a report on Tuesday, October 9th. They issued a “buy” rating and a $92.00 target price for the company. Finally, Stifel Nicolaus raised Nu Skin Enterprises from a “sell” rating to a “hold” rating and raised their target price for the company from $57.00 to $70.00 in a report on Thursday, August 2nd. They noted that the move was a valuation call. One analyst has rated the stock with a sell rating, two have issued a hold rating and five have issued a buy rating to the stock. Nu Skin Enterprises presently has a consensus rating of “Buy” and a consensus target price of $86.29.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.
See Also: Is the Dow Jones Industrial Average (DJIA) still relevant?
Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS).
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.